Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials

October 12, 2020 -- At Johnson& Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world. We are committed to providing transparent updates throughout the clinical development...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials